Arteris, Inc. (AIP) stock
AIPNasdaqSemiconductors & Related DevicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30120% above fair value
$19.34−0.85 (-4.21%)
Close on Nov 13, 2026Market cap $950.60MP/E –Yield –
Earnings
Arteris's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 11, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$25.80M
+48.3% on a year earlier
Non-GAAP net loss per share, Q3 FY2026
-$0.02
-$0.09 a year earlier
Latest guidance
Issued
Nov 5, 2026 · 7 items
Quarterly results
Revenue and earnings per share from each of Arteris's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 11, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026after the close | $25.80M | +48.3% | -$0.23 | -$0.02 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026after the close | $24.10M | +46.1% | -$0.30 | -$0.10 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 12, 2026after the close | $22.90M | +38.8% | -$0.17 | -$0.03 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 12, 2026after the close | $20.10M | +29.7% | -$0.19 | -$0.05 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 4, 2025after the close | $17.40M | +18.4% | -$0.21 | -$0.09 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025after the close | $16.50M | +13.0% | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 13, 2025after the close | $16.50M | +27.9% | -$0.20 | -$0.09 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 18, 2025after the close | $15.50M | +24.0% | -$0.20 | -$0.10 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 5, 2024after the close | $14.70M | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 1, 2024after the close | $14.60M | – | -$0.22 | -$0.11 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 2, 2024after the close | $12.90M | -2.3% | -$0.25 | -$0.15 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 20, 2024after the close | $12.50M | +11.6% | -$0.29 | -$0.18 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 4, 2023after the close | $13.20M | +11.9% | -$0.26 | -$0.17 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 28, 2023after the close | $11.20M | -1.8% | -$0.21 | -$0.12 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 8, 2022after the close | $12.60M | +40.0% | -$0.23 | -$0.13 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 9, 2022after the close | $14.80M | – | -$0.18 | -$0.07 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 10, 2022after the close | $11.80M | – | -$0.22 | -$0.14 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 3, 2022after the close | $11.40M | – | -$0.27 | -$0.12 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 30, 2021after the close | $9.00M | – | -$0.24 | -$0.21 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Arteris's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| RevenueGAAP | Q4 FY2026 | $25.70M – $26.70M | – | New | Nov 5, 2026 |
| Non-GAAP operating (loss) incomenon-GAAP | Q4 FY2026 | -$900.00K – $1.10M | – | New | Nov 5, 2026 |
| ACV + royalties | Q4 FY2026 | $103.00M – $107.00M | – | New | Nov 5, 2026 |
| RevenueGAAP | FY2026 | $98.50M – $99.50M | – | New | Nov 5, 2026 |
| Revenue | FY2026 | $95.00M – $98.00M | $91.00M – $95.00M | Raised | Aug 6, 2026 |
| Non-GAAP operating (loss) incomenon-GAAP | FY2026 | -$9.20M – -$7.20M | – | New | Nov 5, 2026 |
| Non-GAAP operating lossnon-GAAP | FY2026 | $7.00M – $10.00M | -$9.00M – -$5.00M | Raised | Aug 6, 2026 |
| Free cash flownon-GAAP | FY2026 | $5.00M – $9.00M | – | New | Nov 5, 2026 |
| Free cash flownon-GAAP | FY2026 | $5.00M – $9.00M | $5.00M – $9.00M | Reaffirmed | Aug 6, 2026 |
| ACV + royalties | FY2026 | $103.00M – $107.00M | – | New | Nov 5, 2026 |
| ACV + royalties | FY2026 | $102.00M – $106.00M | $102.00M – $106.00M | Reaffirmed | Aug 6, 2026 |
| Non-GAAP operating lossnon-GAAP | FY2026 | $4.50M – $8.50M | – | New | May 12, 2026 |
Guidance vs results
The last range Arteris gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Revenue | $24.00M – $25.00M | $25.80M | Above range |
| Q2 FY2026 | Revenue | $23.00M – $24.00M | $24.10M | Above range |
| Q1 FY2026 | Revenue | $20.50M – $21.50M | $22.90M | Above range |
| FY2025 | Revenue | $68.80M – $69.20M | $70.50MΣ4Q | Above range |
| Q4 FY2025 | Revenue | $18.40M – $18.80M | $20.10M | Above range |
| Q2 FY2025 | Revenue | $16.10M – $16.50M | $16.50M | Within range |
| Q1 FY2025 | Revenue | $15.70M – $16.10M | $16.50M | Above range |
| Q3 FY2024 | Revenue | $14.20M – $15.20M | $14.70M | Within range |
| Q2 FY2024 | Revenue | $13.20M – $14.20M | $14.60M | Above range |
| Q1 FY2024 | Revenue | $12.10M – $13.10M | $12.90M | Within range |
| Q4 FY2022 | Revenue | $10.80M – $11.80M | $11.20M | Within range |
| Q3 FY2022 | Revenue | $10.50M – $12.50M | $12.60M | Above range |
| Q2 FY2022 | Revenue | $11.50M – $14.50M | $14.80M | Above range |
| Q1 FY2022 | Revenue | $10.00M – $12.00M | $11.80M | Within range |
| Q4 FY2021 | Revenue | $10.00M – $11.10M | $11.40M | Above range |
Guidance history
Every forecast Arteris put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 5, 2026 | Free cash flow | FY2026 | $5.00M – $9.00M | New |
| Nov 5, 2026 | Non-GAAP operating (loss) income | Q4 FY2026 | -$900.00K – $1.10M | New |
| Nov 5, 2026 | Non-GAAP operating (loss) income | FY2026 | -$9.20M – -$7.20M | New |
| Nov 5, 2026 | ACV + royalties | Q4 FY2026 | $103.00M – $107.00M | New |
| Nov 5, 2026 | ACV + royalties | FY2026 | $103.00M – $107.00M | New |
| Nov 5, 2026 | Revenue | Q4 FY2026 | $25.70M – $26.70M | New |
| Nov 5, 2026 | Revenue | FY2026 | $98.50M – $99.50M | New |
| Aug 6, 2026 | Free cash flow | FY2026 | $5.00M – $9.00M | Reaffirmed |
| Aug 6, 2026 | Non-GAAP operating loss | FY2026 | $7.00M – $10.00M | Raised |
| Aug 6, 2026 | Non-GAAP operating loss | Q3 FY2026 | $1.00M – $3.00M | New |
| Aug 6, 2026 | ACV + royalties | FY2026 | $102.00M – $106.00M | Reaffirmed |
| Aug 6, 2026 | ACV + royalties | Q3 FY2026 | $99.00M – $103.00M | New |
| Aug 6, 2026 | Revenue | FY2026 | $95.00M – $98.00M | Raised |
| Aug 6, 2026 | Revenue | Q3 FY2026 | $24.00M – $25.00M | New |
| May 12, 2026 | Free cash flow | FY2026 | $5.00M – $9.00M | Reaffirmed |
| May 12, 2026 | Free cash flow | Q2 FY2026 | $2.00M – $8.00M | New |
| May 12, 2026 | ACV + royalties | Q2 FY2026 | $95.00M – $99.00M | New |
| May 12, 2026 | ACV + royalties | FY2026 | $102.00M – $106.00M | Raised |
| May 12, 2026 | Non-GAAP operating loss | FY2026 | $4.50M – $8.50M | New |
| May 12, 2026 | Non-GAAP operating loss | Q2 FY2026 | $2.00M – $3.00M | New |
| May 12, 2026 | Revenue | Q2 FY2026 | $23.00M – $24.00M | New |
| May 12, 2026 | Revenue | FY2026 | $91.00M – $95.00M | Raised |
| Feb 12, 2026 | Free cash flow | FY2026 | $5.00M – $9.00M | New |
| Feb 12, 2026 | Free cash flow | Q1 FY2026 | -$1.50M – $1.50M | New |
| Feb 12, 2026 | Non-GAAP operating loss | Q1 FY2026 | -$3.50M – -$2.50M | New |
| Feb 12, 2026 | Non-GAAP operating loss | FY2026 | -$9.00M – -$5.00M | New |
| Feb 12, 2026 | ACV + royalties | FY2026 | $100.00M – $104.00M | New |
| Feb 12, 2026 | ACV + royalties | Q1 FY2026 | $85.00M – $89.00M | New |
| Feb 12, 2026 | Revenue | FY2026 | $89.00M – $93.00M | New |
| Feb 12, 2026 | Revenue | Q1 FY2026 | $20.50M – $21.50M | New |
| Nov 4, 2025 | Free cash flow | FY2025 | $2.50M – $5.50M | New |
| Nov 4, 2025 | Free cash flow | Q4 FY2025 | $200.00K – $3.20M | New |
| Nov 4, 2025 | Non-GAAP operating loss | FY2025 | $12.50M – $13.50M | New |
| Nov 4, 2025 | Non-GAAP operating loss | Q4 FY2025 | $2.30M – $3.30M | New |
| Nov 4, 2025 | ACV + royalties | FY2025 | $74.00M – $78.00M | New |
| Nov 4, 2025 | ACV + royalties | Q4 FY2025 | $74.00M – $78.00M | New |
| Nov 4, 2025 | Revenue | FY2025 | $68.80M – $69.20M | New |
| Nov 4, 2025 | Revenue | Q4 FY2025 | $18.40M – $18.80M | New |
| May 13, 2025 | Free cash flow | Q2 FY2025 | -$5.00M – $0 | New |
| May 13, 2025 | Free cash flow | FY2025 | $0 – $8.00M | Reaffirmed |
| May 13, 2025 | Non-GAAP operating loss | Q2 FY2025 | $3.00M – $4.00M | New |
| May 13, 2025 | Non-GAAP operating loss | FY2025 | $7.00M – $14.00M | Reaffirmed |
| May 13, 2025 | ACV + royalties | Q2 FY2025 | $66.00M – $70.00M | New |
| May 13, 2025 | ACV + royalties | FY2025 | $71.00M – $79.00M | Reaffirmed |
| May 13, 2025 | Revenue | Q2 FY2025 | $16.10M – $16.50M | New |
| May 13, 2025 | Revenue | FY2025 | $65.00M – $71.00M | Reaffirmed |
| Feb 18, 2025 | Free cash flow | Q1 FY2025 | -$2.00M – $2.00M | New |
| Feb 18, 2025 | Free cash flow | FY2025 | $1.00M – $7.00M | New |
| Feb 18, 2025 | Non-GAAP operating loss | Q1 FY2025 | $3.00M – $4.00M | New |
| Feb 18, 2025 | Non-GAAP operating loss | FY2025 | $8.50M – $12.50M | New |
| Feb 18, 2025 | ACV + royalties | Q1 FY2025 | $65.50M – $67.50M | New |
| Feb 18, 2025 | ACV + royalties | FY2025 | $73.00M – $77.00M | New |
| Feb 18, 2025 | Revenue | Q1 FY2025 | $15.70M – $16.10M | New |
| Feb 18, 2025 | Revenue | FY2025 | $66.00M – $70.00M | New |
| Aug 1, 2024 | Free cash flow | Q3 FY2024 | -$1.40M – $1.60M | New |
| Aug 1, 2024 | Free cash flow | FY2024 | -$2.40M – $2.60M | Reaffirmed |
| Aug 1, 2024 | Non-GAAP operating loss | Q3 FY2024 | $3.50M – $5.50M | New |
| Aug 1, 2024 | Non-GAAP operating loss | FY2024 | $18.00M – $22.00M | Lowered |
| Aug 1, 2024 | ACV + TTM royalties | Q3 FY2024 | $58.50M – $62.50M | New |
| Aug 1, 2024 | ACV + TTM royalties | FY2024 | $62.00M – $68.00M | Reaffirmed |
| Aug 1, 2024 | Revenue | Q3 FY2024 | $14.20M – $15.20M | New |
| Aug 1, 2024 | Revenue | FY2024 | $56.00M – $58.00M | Raised |
| May 2, 2024 | Free cash flow | Q2 FY2024 | -$1.40M – $1.60M | New |
| May 2, 2024 | Free cash flow | FY2024 | -$2.40M – $2.60M | New |
| May 2, 2024 | Non-GAAP operating loss | Q2 FY2024 | $4.50M – $6.50M | New |
| May 2, 2024 | Non-GAAP operating loss | FY2024 | $19.40M – $23.40M | New |
| May 2, 2024 | ACV + TTM royalties | Q2 FY2024 | $58.00M – $62.00M | New |
| May 2, 2024 | ACV + TTM royalties | FY2024 | $62.00M – $68.00M | Reaffirmed |
| May 2, 2024 | Revenue | Q2 FY2024 | $13.20M – $14.20M | New |
| May 2, 2024 | Revenue | FY2024 | $54.50M – $57.50M | Reaffirmed |
| Feb 20, 2024 | Free cash flow (%) | Q1 FY2024 | -9.2% – 10.8% | New |
| Feb 20, 2024 | Free cash flow (%) | FY2024 | -4.8% – 5.2% | New |
| Feb 20, 2024 | Non-GAAP operating loss (%) | Q1 FY2024 | 40.8% – 60.8% | New |
| Feb 20, 2024 | Non-GAAP operating loss (%) | FY2024 | 33.2% – 43.2% | New |
| Feb 20, 2024 | ACV + TTM royalties | Q1 FY2024 | $55.00M – $59.00M | New |
| Feb 20, 2024 | ACV + TTM royalties | FY2024 | $62.00M – $68.00M | New |
| Feb 20, 2024 | Revenue | Q1 FY2024 | $12.10M – $13.10M | New |
| Feb 20, 2024 | Revenue | FY2024 | $54.50M – $57.50M | New |
| May 4, 2023 | Free cash flow (%) | Q2 FY2023 | -51.8% – -26.8% | New |
| May 4, 2023 | Free cash flow (%) | FY2023 | -19.7% – -9.7% | New |
| May 4, 2023 | Non-GAAP operating loss (%) | Q2 FY2023 | 37% – 57% | New |
| May 4, 2023 | Non-GAAP operating loss (%) | FY2023 | 28.5% – 43.5% | New |
| May 4, 2023 | ACV + TTM royalties | Q2 FY2023 | $53.50M – $57.50M | New |
| May 4, 2023 | ACV + TTM royalties | FY2023 | $60.40M – $65.40M | New |
| May 4, 2023 | Revenue | Q2 FY2023 | $13.00M – $14.00M | New |
| May 4, 2023 | Revenue | FY2023 | $56.00M – $60.00M | New |
| Nov 8, 2022 | Free cash flow (%) | Q4 FY2022 | -47.1% – -13.1% | New |
| Nov 8, 2022 | Free cash flow (%) | FY2022 | -24.6% – -16.6% | Narrowed |
| Nov 8, 2022 | Non-GAAP operating loss (%) | Q4 FY2022 | 50.2% – 70.2% | New |
| Nov 8, 2022 | Non-GAAP operating loss (%) | FY2022 | 31.6% – 36.1% | Narrowed |
| Nov 8, 2022 | ACV + TTM royalties | Q4 FY2022 | $47.50M – $51.50M | New |
| Nov 8, 2022 | ACV + TTM royalties | FY2022 | $47.50M – $51.50M | Lowered |
| Nov 8, 2022 | Revenue | Q4 FY2022 | $10.80M – $11.80M | New |
| Nov 8, 2022 | Revenue | FY2022 | $50.00M – $51.00M | Narrowed |
| Aug 9, 2022 | Free cash flow (%) | Q3 FY2022 | -56.2% – -41.2% | New |
| Aug 9, 2022 | Free cash flow (%) | FY2022 | -25.1% – -10.1% | Raised |
| Aug 9, 2022 | Non-GAAP operating loss (%) | Q3 FY2022 | 41.2% – 56.2% | New |
| Aug 9, 2022 | Non-GAAP operating loss (%) | FY2022 | 24.3% – 39.3% | Lowered |
| Aug 9, 2022 | ACV + TTM royalties | Q3 FY2022 | $51.00M – $53.00M | New |
| Aug 9, 2022 | ACV + TTM royalties | FY2022 | $48.00M – $52.00M | Lowered |
| Aug 9, 2022 | Revenue | Q3 FY2022 | $10.50M – $12.50M | New |
| Aug 9, 2022 | Revenue | FY2022 | $49.50M – $52.50M | Raised |
| May 10, 2022 | Free cash flow (%) | Q2 FY2022 | -44.4% – -29.4% | New |
| May 10, 2022 | Free cash flow (%) | FY2022 | -25.5% – -10.5% | Raised |
| May 10, 2022 | Non-GAAP operating loss (%) | Q2 FY2022 | 19.4% – 34.4% | New |
| May 10, 2022 | Non-GAAP operating loss (%) | FY2022 | 24.9% – 39.9% | Lowered |
| May 10, 2022 | ACV + TTM royalties | Q2 FY2022 | $49.50M – $51.50M | New |
| May 10, 2022 | ACV + TTM royalties | FY2022 | $51.60M – $55.60M | Reaffirmed |
| May 10, 2022 | Revenue | Q2 FY2022 | $11.50M – $14.50M | New |
| May 10, 2022 | Revenue | FY2022 | $48.00M – $52.00M | Raised |
| Mar 3, 2022 | Free cash flow (%) | Q1 FY2022 | -38% – -23% | New |
| Mar 3, 2022 | Free cash flow (%) | FY2022 | -25.9% – -10.9% | New |
| Mar 3, 2022 | Non-GAAP operating loss (%) | Q1 FY2022 | 41.1% – 56.1% | New |
| Mar 3, 2022 | Non-GAAP operating loss (%) | FY2022 | 25.6% – 40.6% | New |
| Mar 3, 2022 | ACV + TTM royalties | Q1 FY2022 | $50.50M – $52.50M | New |
| Mar 3, 2022 | ACV + TTM royalties | FY2022 | $51.60M – $55.60M | New |
| Mar 3, 2022 | Revenue | Q1 FY2022 | $10.00M – $12.00M | New |
| Mar 3, 2022 | Revenue | FY2022 | $47.00M – $51.00M | New |
| Nov 30, 2021 | Free cash flow (%) | Q4 FY2021 | -52% – -37% | New |
| Nov 30, 2021 | Free cash flow (%) | FY2021 | -35% – -20% | New |
| Nov 30, 2021 | Non-GAAP operating loss (%) | Q4 FY2021 | 32% – 54% | New |
| Nov 30, 2021 | Non-GAAP operating loss (%) | FY2021 | 40% – 50% | New |
| Nov 30, 2021 | ACV + TTM royalties | Q4 FY2021 | $48.50M – $50.00M | New |
| Nov 30, 2021 | ACV + TTM royalties | FY2021 | $48.50M – $50.00M | New |
| Nov 30, 2021 | Revenue | Q4 FY2021 | $10.00M – $11.10M | New |
| Nov 30, 2021 | Revenue | FY2021 | $36.30M – $37.50M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Arteris filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?